{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:59:49Z","timestamp":1782917989677,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:00:00Z","timestamp":1407801600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The persistence of triptan use among newly prescribed users is low in the United States and European countries. However, triptan refill patterns in Asian primary care practices have not been well described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data from the National Health Insurance Research Database in Taiwan were used to conduct a retrospective cohort analysis from 2005 to 2008. All participants were followed for 2\u00a0years after receiving a new triptan prescription. Refill and 2-year retention rates of newly prescribed triptans were calculated, and predictors of the first triptan refill and 2-year retention were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 13,951 participants with a new triptan prescription (99.9% sumatriptan), 67.4% were prescribed by a neurologist, 67.4% were prescribed at least one prophylactic agent for migraine. Of them, 34.3% adhered to the newly prescribed triptan at the first refill, 0.01% switched to another triptan, and 40.9% switched to a non-triptan acute migraine medication. The 2-year retention rate was 4.0%. The frequency of headache-related neurologic visits for 1\u00a0year before the index date, first prescription of triptan or other acute medications, first triptan prescription by a neurologist, and prophylactic use were associated with higher first refill rates. The frequency of headache-related neurologic visits 1\u00a0year before the index date and first triptan prescription by a neurologist were related to higher 2-year retention rates. Diabetes mellitus and first triptan prescription at a local medical clinic were associated with reduced probability of continued triptan use at the first refill and 2\u00a0years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Similar to Western societies, the refill and 2-year retention rates were low in new users of triptans. Frequency of neurologic visits and triptan prescription by a neurologist were significant predictors of adherence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1129-2377-15-48","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T15:02:05Z","timestamp":1407855725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Treatment adherence among new triptan users: a 2-year cohort study in Taiwan"],"prefix":"10.1186","volume":"15","author":[{"given":"Ting-Bin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Tai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ling","family":"Fuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hsiun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuu-Jiun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,12]]},"reference":[{"issue":"2","key":"634_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1726-4901(08)70078-9","volume":"71","author":"JL Fuh","year":"2008","unstructured":"Fuh JL, Wang SJ, Lu SR: Impact of migraine on the employed labor force in Taiwan. J Chin Med Assoc 2008, 71(2):74\u201378.","journal-title":"J Chin Med Assoc"},{"issue":"6","key":"634_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1046\/j.1468-2982.2000.00085.x","volume":"20","author":"SJ Wang","year":"2000","unstructured":"Wang SJ, Fuh JL, Young YH, Lu SR, Shia BC: Prevalence of migraine in Taipei, Taiwan: a population-based survey. Cephalalgia 2000, 20(6):566\u2013572.","journal-title":"Cephalalgia"},{"issue":"9","key":"634_CR3","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1526-4610.2005.00250.x","volume":"45","author":"SD Silberstein","year":"2005","unstructured":"Silberstein SD, Dodick D, Kesslick J: Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size. Headache 2005, 45(9):1250\u20131254.","journal-title":"Headache"},{"issue":"8","key":"634_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1526-4610.2005.05182.x","volume":"45","author":"JS Brown","year":"2005","unstructured":"Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J: Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment. Headache 2005, 45(8):1012\u20131022.","journal-title":"Headache"},{"issue":"11","key":"634_CR5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/0333102413480756","volume":"33","author":"M Viana","year":"2013","unstructured":"Viana M, Genazzani AA, Terrazzino S, Nappi G, Goadsby PJ: Triptan nonresponders: do they exist and who are they? Cephalalgia 2013, 33(11):891\u2013896.","journal-title":"Cephalalgia"},{"issue":"4","key":"634_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/0333102413508661","volume":"34","author":"K Thorlund","year":"2014","unstructured":"Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ: Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis. Cephalalgia 2014, 34(4):258\u2013267.","journal-title":"Cephalalgia"},{"issue":"9","key":"634_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","volume":"16","author":"S Evers","year":"2009","unstructured":"Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS: EFNS guideline on the drug treatment of migraine\u2013revised report of an EFNS task force. Eur J Neurol 2009, 16(9):968\u2013981.","journal-title":"Eur J Neurol"},{"issue":"6 Suppl 1","key":"634_CR8","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1212\/WNL.56.suppl_1.S35","volume":"56","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Silberstein SD: The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology 2001, 56(6 Suppl 1):S35-S42.","journal-title":"Neurology"},{"issue":"10","key":"634_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.7326\/0003-4819-137-10-200211190-00014","volume":"137","author":"V Snow","year":"2002","unstructured":"Snow V, Weiss K, Wall EM, Mottur-Pilson C: Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002, 137(10):840\u2013849.","journal-title":"Ann Intern Med"},{"issue":"6","key":"634_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/WNL.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD: Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology. Neurology 2000, 55(6):754\u2013762.","journal-title":"Neurology"},{"issue":"Suppl 7","key":"634_CR11","first-page":"1","volume":"8","author":"J Olesen","year":"1988","unstructured":"Olesen J, Bes A, Kunkel R, Lance JW, Nappi G, Pfaffenrath V, Rose FC, Schoenberg BS, Soyka D, Tfelt-Hansen P, Welch KMA, Wilkinson M: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the international headache society. Cephalalgia 1988, 8(Suppl 7):1\u201396.","journal-title":"Cephalalgia"},{"issue":"3","key":"634_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/head.12074","volume":"53","author":"TA Smitherman","year":"2013","unstructured":"Smitherman TA, Burch R, Sheikh H, Loder E: The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache 2013, 53(3):427\u2013436.","journal-title":"Headache"},{"issue":"9","key":"634_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1468-2982.2007.01401.x","volume":"27","author":"E Pavone","year":"2007","unstructured":"Pavone E, Banfi R, Vaiani M, Panconesi A: Patterns of triptans use: a study based on the records of a community pharmaceutical department. Cephalalgia 2007, 27(9):1000\u20131004.","journal-title":"Cephalalgia"},{"issue":"9","key":"634_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1046\/j.1526-4610.2002.02211.x","volume":"42","author":"L Robbins","year":"2002","unstructured":"Robbins L: Triptans versus analgesics. Headache 2002, 42(9):903\u2013907.","journal-title":"Headache"},{"issue":"8","key":"634_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1046\/j.1468-2982.2000.00116.x","volume":"20","author":"KM Welch","year":"2000","unstructured":"Welch KM, Mathew NT, Stone P, Rosamond W, Saiers J, Gutterman D: Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 2000, 20(8):687\u2013695.","journal-title":"Cephalalgia"},{"issue":"4","key":"634_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/0333102410383058","volume":"31","author":"BJ Katic","year":"2011","unstructured":"Katic BJ, Rajagopalan S, Ho TW, Chen YT, Hu XH: Triptan persistency among newly initiated users in a pharmacy claims database. Cephalalgia 2011, 31(4):488\u2013500.","journal-title":"Cephalalgia"},{"issue":"12","key":"634_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/0333102412449929","volume":"32","author":"DS Ng-Mak","year":"2012","unstructured":"Ng-Mak DS, Chen YT, Ho TW, Stanford B, Roset M: Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases. Cephalalgia 2012, 32(12):875\u2013887.","journal-title":"Cephalalgia"},{"issue":"2","key":"634_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/ije\/29.2.336","volume":"29","author":"TH Lu","year":"2000","unstructured":"Lu TH, Lee MC, Chou MC: Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol 2000, 29(2):336\u2013343.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"634_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML: Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011, 20(3):236\u2013242.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"634_CR20","unstructured":"2013 Annaul Report of Global Budget System of Taiwan National Health Insurance. 2013. . Accessed Sept 2013 http:\/\/www.mohw.gov.tw\/MOHW_Upload\/doc\/102%E5%B9%B4%E6%8C%87%E6%A8%99%E8%A6%81%E8%A6%BD_0000674001.pdf"},{"issue":"7","key":"634_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/0333102409357956","volume":"30","author":"A Ferrari","year":"2010","unstructured":"Ferrari A, Spaccapelo L, Sternieri E: Pharmacoepidemiology of triptans in a headache centre. Cephalalgia 2010, 30(7):847\u2013854.","journal-title":"Cephalalgia"},{"issue":"2","key":"634_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/head.12198","volume":"54","author":"RE Wells","year":"2013","unstructured":"Wells RE, Markowitz SY, Baron EP, Hentz JG, Kalidas K, Mathew PG, Halker R, Dodick DW, Schwedt TJ: Identifying the factors underlying discontinuation of triptans. Headache 2013, 54(2):278\u2013289.","journal-title":"Headache"},{"issue":"3","key":"634_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1526-4610.2009.01343.x","volume":"49","author":"RK Cady","year":"2009","unstructured":"Cady RK, Maizels M, Reeves DL, Levinson DM, Evans JK: Predictors of adherence to triptans: factors of sustained vs lapsed users. Headache 2009, 49(3):386\u2013394.","journal-title":"Headache"},{"issue":"5","key":"634_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/ewjm.173.5.341","volume":"173","author":"D Parsekyan","year":"2000","unstructured":"Parsekyan D: Migraine prophylaxis in adult patients. West J Med 2000, 173(5):341\u2013345.","journal-title":"West J Med"},{"issue":"12","key":"634_CR25","first-page":"1057","volume":"55","author":"A Walling","year":"2006","unstructured":"Walling A, Woolley DC, Molgaard C, Kallail KJ: Do family physicians fail to provide triptans for patients with migraine? J Fam Pract 2006, 55(12):1057\u20131062.","journal-title":"J Fam Pract"},{"issue":"3","key":"634_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1185\/030079905X36387","volume":"21","author":"RB Lipton","year":"2005","unstructured":"Lipton RB, Cutrer FM, Goadsby PJ, Ferrari MD, Dodick DW, McCrory D, Liberman JN, Williams P: How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians. Curr Med Res Opin 2005, 21(3):413\u2013424.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"634_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/13548506.2010.498921","volume":"15","author":"AM Brincks","year":"2010","unstructured":"Brincks AM, Feaster DJ, Burns MJ, Mitrani VB: The influence of health locus of control on the patient-provider relationship. Psychol Health Med 2010, 15(6):720\u2013728.","journal-title":"Psychol Health Med"},{"issue":"3","key":"634_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1468-2982.2005.01041.x","volume":"26","author":"SR Lu","year":"2006","unstructured":"Lu SR, Wang SJ, Fuh JL: The practice pattern of migraine management among neurologists in Taiwan. Cephalalgia 2006, 26(3):310\u2013313.","journal-title":"Cephalalgia"},{"issue":"2","key":"634_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10194-008-0020-3","volume":"9","author":"A Panconesi","year":"2008","unstructured":"Panconesi A, Pavone E, Vacca F, Vaiani M, Banfi R: Triptans in the Italian population: a drug utilization study and a literature review. J Headache Pain 2008, 9(2):71\u201376.","journal-title":"J Headache Pain"},{"issue":"8","key":"634_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1468-2982.1999.019008735.x","volume":"19","author":"D Gaist","year":"1999","unstructured":"Gaist D: Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Cephalalgia 1999, 19(8):735\u2013761.","journal-title":"Cephalalgia"},{"issue":"1","key":"634_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/02813430500444916","volume":"24","author":"J Sondergaard","year":"2006","unstructured":"Sondergaard J, Foged A, Kragstrup J, Gaist D, Gram LF, Sindrup SH, Muckadell HU, Larsen BO, Herborg H, Andersen M: Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial. Scand J Prim Health Care 2006, 24(1):16\u201321.","journal-title":"Scand J Prim Health Care"},{"issue":"2","key":"634_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1526-4610.2005.05031.x","volume":"45","author":"DW Dodick","year":"2005","unstructured":"Dodick DW: Triptan nonresponder studies: implications for clinical practice. Headache 2005, 45(2):156\u2013162.","journal-title":"Headache"},{"issue":"2","key":"634_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1468-2982.2005.01010.x","volume":"26","author":"CG Dahlof","year":"2006","unstructured":"Dahlof CG: Infrequent or non-response to oral sumatriptan does not predict response to other triptans\u2013review of four trials. Cephalalgia 2006, 26(2):98\u2013106.","journal-title":"Cephalalgia"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1129-2377-15-48\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1129-2377-15-48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1129-2377-15-48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:44:52Z","timestamp":1630561492000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/1129-2377-15-48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1186\/1129-2377-15-48","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,12]]},"assertion":[{"value":"6 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"48"}}